Crown Equity Holdings Inc., (CRWE)

Crown Equity Holdings Inc. (CRWE) recently announced that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.

Commenting on the joint venture, Kenneth Bosket, President of Crown Equity Holdings Inc., said: “We are excited to deliver VoIP communications solutions specifically designed to meet the business and residential market needs in this fast-growing global market.”

Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.

Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.

CRWE’s digital network is designed, on behalf of its clients, to bring together targeted high-income audiences and advertisers on its financial websites that include, among others, DrStockPick.com, PennyOmega.com, BestOtc.com, CRWEFinance.com, CRWESelect.com, CRWEPicks.com and StockHotTips.com.

Internet marketing is a very cost effective option of promoting your business. Your business website can only take you to a certain level if you do not make the effort to increase its visibility. Internet marketing will make your business promotion dynamic and lively at a very nominal cost.

For more information, please visit their website: http://www.crownequityholdings.com

*********************************************

West Pharmaceutical Services, Inc. (NYSE:WST) announced that it will release 2011 third quarter financial results before the market opens on Tuesday, November 1, 2011 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-638-4930 (U.S.) or 617-614-3944 (International). The passcode is 60536446.

West Pharmaceutical Services, Inc. manufactures and sells components and systems for injectable drug delivery and plastic packaging, and delivery system components for the pharmaceutical, healthcare, and consumer products industries.

*********************************************

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, November 3, 2011 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the 2011 third quarter.

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. Its product portfolio comprises approximately 490 products.

*********************************************

Cymer Inc. (Nasdaq:CYMI), the world’s leading supplier of light sources used by chipmakers to create advanced semiconductor chips, announced operating results for the third quarter ended September 30, 2011. Net income totaled $11.3 million, equal to $0.36 per share (diluted), compared to net income of $20.9 million, equal to $0.70 per share (diluted) in the third quarter of 2010 and net income of $27.7 million, equal to $0.89 per share (diluted) in the second quarter of 2011. Revenue totaled $128.7 million compared to revenue of $141.7 million in the third quarter of 2010, and revenue of $158.2 million in the second quarter of 2011.

Cymer, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of excimer light sources for the manufacturers of photolithography tools in the semiconductor equipment industry.

Sign up for free stock alerts at http://www.pennygovernance.com/signup

***************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyGovernance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyGovernance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.(read more @ http://pennygovernance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

<